Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYH11-positive acute myeloblastic leukemia.

which will significantly reduce both materials and costs for labora4. Sala N, Owen WG, Collen D: A functional assay for protein tory tests. C in human plasma. Blood 63:671, 1984 5. Dang QD, Vindigni A, Di Cera E: An allosteric switch controls ACKNOWLEDGMENT the pro-coagulant and anti-coagulant activities of thrombin. Proc Natl Acad Sci USA 92:5977, 1995 Supported by National Institutes of Health Research Grant No. 6. Cho K, Tanaka T, Cook RR, Kiesel W, Fujikawa K, Kurachi HL49413 and a grant from the American Heart Association. E.D.C. K: Active site mapping of bovine blood coagulation serine proteases is an Established Investigator of the American Heart Association using synthetic peptide 4-nitroanilide and thio ester substrates. Bioand Genentech. chemistry 25:2417, 1986 7. Butenas S, Orfeo T, Lawson JH, Mann KG: AminonaphthaQuoc D. Dang lenesulfonamides, a new class of modifiable fluorescent detecting Enrico Di Cera groups and their use in substrates for serine protease enzymes. BioDepartment of Biochemistry and Molecular Biophysics chemistry 31:5399, 1992 Washington University School of Medicine 8. Butenas S, Drungilaite V, Mann KG: Fluorogenic substrates St Louis, MO for activated protein C: Substrate structure-efficiency correlation. REFERENCES Anal Biochem 225:231, 1995 9. Guinto ER, Esmon CT, Mann KG, MacGillivray RTA: The 1. Claeson G: Synthetic peptides and peptidomimetics as subcomplete cDNA sequence of bovine coagulation factor V. J Biol strates and inhibitors of thrombin and other proteases in the blood Chem 267:2971, 1992 coagulation system. Blood Coagul Fibrin 5:411, 1994 10. Bode W, Turk D, Karshikov A: The refined 1.9-Å X-ray 2. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: crystal structure of D-Phe-Pro-Arg-chloromethylketone-inhibited Initiation, maintenance and regulation. Biochemistry 30:10363, 1991 human a-thrombin: Structure analysis, overall structure, electrostatic 3. Dalbäck B: Inherited thrombophilia: Resistance to activated properties, detailed active-site geometry, and structure-function relaprotein C as a pathogenic factor of venous thromboembolism. Blood tionships. Protein Sci 1:426, 1992 85:607, 1995